2nd Columbia Pediatric Heart Valve Symposium: From Bench to Bedside

2nd Columbia Pediatric Heart Valve Symposium: From Bench to Bedside is organized by Columbia University Medical Center (CUMC) and will be held from Apr 30 - May 01, 2019 at Vivian And Seymour Milstein Family Heart Center, New York City, New York, United States of America.

Target Audience
This activity is designed for congenital and pediatric cardiac surgeons, pediatric cardiologists, pediatric interventional cardiologists, general pediatricians, intensivists, RNs, NPs, PAs and other medical professionals involved the evaluation, diagnosis and/or management of patients with congenital heart disease.

Accreditation Statement
Credit Designation Statement
Physician:
Amedco designates this live activity for a maximum of 10.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PhysicianAssistant
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 10.0 AMA PRA Category 1 CreditsTM for completing this activity.

Description:
The 2nd Columbia Pediatric Heart Valve Symposium: From Bench to Bedside is the Second Annual Cardiovascular Therapy Course focusing on medical and surgical management of congenital heart valve disease, hosted by NewYork-Presbyterian/Columbia University Irving Medical Center. This program represents a unique multidisciplinary collaboration between congenital and pediatric cardiac surgeons, adult congenital cardiologists, pediatric cardiologists, pediatric interventional cardiologists, and heart valve scientists, allowing for a truly comprehensive approach to the management of children and adults with congenital heart valve malformations.

This one and a half-day course will further educate on the surgical and interventional management of patients with congenital heart valve malformations. Lectures will be given by internationally recognized experts who will review standard and emerging treatments for patients with congenital heart valve malformations, address the newest and most innovative therapies and review clinical, basic science and translational research programs, exploring edge-cutting and disruptive concepts to develop new valve devices. Such collaboration will ultimately improve care in children and adults with congenital heart valve malformations, thanks to a constant dialogue and works from bench to bed and back from bed to the bench. Didactic sessions, case presentations, and interactive discussions will engender learning and improvement in the management of patients with the full spectrum of congenital heart valve malformations.

Learning Objectives
• Describe the outcomes of established and new surgical procedures and transcatheter therapies for the treatment of congenital heart valve diseases
• Explain the current imaging modalities and indications to follow and treat congenital heart valve diseases
• Discuss the most recent advances in basic science research and translational research related to congenital heart valve diseases